---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-035028"
form_type: "8-K"
ticker: "SLS"
cik: "0001390478"
company_name: "SELLAS Life Sciences Group, Inc."
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T16:56:22.381930+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SELLAS raises ~$20M in registered direct offering plus warrants priced at $1.535/share

## Summary
- Gross proceeds of ~$20M from sale of 13,029,316 shares (or pre-funded warrants) at $1.535/share on Nasdaq.
- Concurrent private placement of warrants to purchase up to 13,029,316 shares at $1.41, exercisable for 5.5 years.
- Offering includes warrants exercisable immediately; closing expected March 19, 2024.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- A.G.P./Alliance Global Partners acting as sole placement agent with 7% cash fee.

## SEC filing metadata
- accession: 0001104659-24-035028
- form_type: 8-K
- ticker: SLS
- cik: 0001390478
- company_name: SELLAS Life Sciences Group, Inc.
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/0001104659-24-035028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/tm248987d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-035028
- JSON: https://secwatch.observer/filing/0001104659-24-035028.json
- Plain text: https://secwatch.observer/filing/0001104659-24-035028.txt

## Key facts
- Material Agreements
  SELLAS Life Sciences Group, Inc. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners (effective 2024-03-15).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners
  - Effective: 2024-03-15
  source text: On March 15, 2024, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) (the “Placement Agent”) pursuant to which the Company engaged A.G.P. as the exclusive placement agent in connection with the Offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/0001104659-24-035028-index.htm
- Material Agreements
  SELLAS Life Sciences Group, Inc. entered into Securities Purchase Agreement with institutional investors valued at approximately $20.0 million (effective 2024-03-15).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investors
  - Value: approximately $20.0 million
  - Effective: 2024-03-15
  source text: On March 15, 2024, SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the “Registered Offering”), (i) an aggregate of 11,000,000 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”) and (ii) an aggregate of 2,029,316 pre-funded warrants exercisable for shares of Common Stock (the “Pre-Funded Warrants”) to the Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/0001104659-24-035028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.